PIIINP and ST2/IL-33R, biomarkers of liver fibrosis, were elevated only in the NAFLD/NASH and ALD patients, suggesting that both biomarkers detect fibrosis and late-stage liver disease. Here, IL1RL1 is linked to metabolic dysfunction-associated steatohepatitis.